Literature DB >> 22573341

On the isomerization of cyclooctyne into cycloocta-1,3-diene: synthesis, characterization and structure of a dinuclear platinum(II) complex with a μ-η2:η2-1,3-COD ligand.

Anja König1, Christoph Wagner, Martin Bette, Dirk Steinborn.   

Abstract

The Zeise's salt type cyclooctyne compound [K(18C6)][PtCl(3)(COC)] (1; COC = cyclooctyne; 18C6 = 18-crown-6) was found to react in chloroform solution at room temperature within several weeks yielding the dinuclear cyclooctadiene compound [K(18C6)](2)[(PtCl(3))(2)(μ-η(2):η(2)-1,3-COD)] (2; 1,3-COD = cycloocta-1,3-diene) and non-coordinated cycloocta-1,3-diene. The identity of 2 was confirmed by microanalysis, NMR spectroscopy ((1)H, (13)C) and electrospray ionization mass spectrometry (ESI-MS). A single-crystal X-ray diffraction analysis of 2 exhibited a bridging μ-η(2):η(2)-cycloocta-1,3-diene ligand with non-conjugated double bonds each coordinated to a PtCl(3) fragment. On the basis of DFT calculations as well as energy decomposition analyses (EDA), charge decomposition analyses (CDA) and natural bond orbital (NBO) analyses the peculiarities of the nature of the Pt-C bonds in the dinuclear complex anion [(PtCl(3))(2)(μ-η(2):η(2)-1,3-COD)](2-) (2a') compared with those in mononuclear olefin complexes of Zeise's salt type [PtCl(3)L](-) (L = η(2)-1,3-COD, 3a'; cis-but-2-ene, 4a'; COE, 5a'; COE = cyclooctene) are discussed. Furthermore, the driving force for the strongly exergonic reaction with formation of the cyclooctadiene complex 2a' was found to be a significant release of ring strain of the cyclooctyne ligand in the starting compound 1.

Entities:  

Year:  2012        PMID: 22573341     DOI: 10.1039/c2dt12405j

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  1 in total

1.  Isomerization of Cyclooctadiene to Cyclooctyne with a Zinc/Zirconium Heterobimetallic Complex.

Authors:  Michael J Butler; Andrew J P White; Mark R Crimmin
Journal:  Angew Chem Int Ed Engl       Date:  2016-04-13       Impact factor: 15.336

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.